Since all of the ββ-lactams that you have tested are susceptible to hydrolysis by PaESBL-1, the hospital will not be able to use a single ββ-lactam to combat this P. aeruginosa isolate. You need to consider alternative strategies. From the following list, select all of the strategies that might successfully overcome the broad substrate specificity of PaESBL-1:

Phlebotomy Essentials
6th Edition
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Chapter1: Phlebotomy: Past And Present And The Healthcare Setting
Section: Chapter Questions
Problem 1SRQ
icon
Related questions
Question

Since all of the ββ-lactams that you have tested are susceptible to hydrolysis by PaESBL-1, the hospital will not be able to use a single ββ-lactam to combat this P. aeruginosa isolate. You need to consider alternative strategies.

From the following list, select all of the strategies that might successfully overcome the broad substrate specificity of PaESBL-1:

Since all of the B-lactams that you have tested are susceptible to hydrolysis by PAESBL-1, the hospital will not be able to use a single 8-lactam to combat this P. aeruginosa isolate. You need to consider
alternative strategies.
From the following list, select all of the strategies that might successfully overcome the broad substrate specificity of PaESBL-1:
Check all that apply.
using multiple B-lactams simultaneously (e.g., rather than treating with amoxicillin alone,
treat with the three B-lactams: amoxicillin, cephalothin, and imipenem).
using a reversible inhibitor of PaESBL-1 instead of a B-lactam.
Treat future infections by
combining a reversible inhibitor of PAESBL-1 with one or more B-lactams.
O using an irreversible inhibitor of PaESBL-1 instead of a B-lactam.
combining an irreversible inhibitor of PAESBL-1 with one or more 8-lactams.
Transcribed Image Text:Since all of the B-lactams that you have tested are susceptible to hydrolysis by PAESBL-1, the hospital will not be able to use a single 8-lactam to combat this P. aeruginosa isolate. You need to consider alternative strategies. From the following list, select all of the strategies that might successfully overcome the broad substrate specificity of PaESBL-1: Check all that apply. using multiple B-lactams simultaneously (e.g., rather than treating with amoxicillin alone, treat with the three B-lactams: amoxicillin, cephalothin, and imipenem). using a reversible inhibitor of PaESBL-1 instead of a B-lactam. Treat future infections by combining a reversible inhibitor of PAESBL-1 with one or more B-lactams. O using an irreversible inhibitor of PaESBL-1 instead of a B-lactam. combining an irreversible inhibitor of PAESBL-1 with one or more 8-lactams.
All of the kinetics work you performed in Parts F through P has allowed you to determine the values of kcat and KM of your enzyme for the substrate amoxicillin. You repeat all of these experiments with a series
of additional 8-lactam substrates, hoping to determine which of the B-lactams are more or less susceptible to hydrolysis by this newly discovered B-lactamase enzyme.
kcat
(s1)
Км
(uM)
Antibiotic
Amoxicillin
7
130
Cephalothin
1,000
6,000
Cefotaxime
14
7,900
Ceftazidime
2.5
20,000
Aztreonam
3.5
5,000
Imipenem
0.09
2.9
"Data based on published data for GES-14 in Table 2 from Delbrück H, Bogaerts P, Kupper MB, Rezende de Castro R, Bennink S, Glupczynski Y, Galleni M, Hoffmann KM, Bebrone C. Kinetic and crystallographic studies of extended-spectrum GES-11,
GES-12, and GES-14 B-lactamases. Antimicrob Agents Chemother. 2012 Nov,56(11):5618.
Transcribed Image Text:All of the kinetics work you performed in Parts F through P has allowed you to determine the values of kcat and KM of your enzyme for the substrate amoxicillin. You repeat all of these experiments with a series of additional 8-lactam substrates, hoping to determine which of the B-lactams are more or less susceptible to hydrolysis by this newly discovered B-lactamase enzyme. kcat (s1) Км (uM) Antibiotic Amoxicillin 7 130 Cephalothin 1,000 6,000 Cefotaxime 14 7,900 Ceftazidime 2.5 20,000 Aztreonam 3.5 5,000 Imipenem 0.09 2.9 "Data based on published data for GES-14 in Table 2 from Delbrück H, Bogaerts P, Kupper MB, Rezende de Castro R, Bennink S, Glupczynski Y, Galleni M, Hoffmann KM, Bebrone C. Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 B-lactamases. Antimicrob Agents Chemother. 2012 Nov,56(11):5618.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Phlebotomy Essentials
Phlebotomy Essentials
Nursing
ISBN:
9781451194524
Author:
Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:
JONES+BARTLETT PUBLISHERS, INC.
Gould's Pathophysiology for the Health Profession…
Gould's Pathophysiology for the Health Profession…
Nursing
ISBN:
9780323414425
Author:
Robert J Hubert BS
Publisher:
Saunders
Fundamentals Of Nursing
Fundamentals Of Nursing
Nursing
ISBN:
9781496362179
Author:
Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:
Wolters Kluwer,
Fundamentals of Nursing, 9e
Fundamentals of Nursing, 9e
Nursing
ISBN:
9780323327404
Author:
Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:
Elsevier Science
Study Guide for Gould's Pathophysiology for the H…
Study Guide for Gould's Pathophysiology for the H…
Nursing
ISBN:
9780323414142
Author:
Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:
Saunders
Issues and Ethics in the Helping Professions (Min…
Issues and Ethics in the Helping Professions (Min…
Nursing
ISBN:
9781337406291
Author:
Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:
Cengage Learning